» Articles » PMID: 26132915

Putative Dopamine Agonist (KB220Z) Attenuates Lucid Nightmares in PTSD Patients: Role of Enhanced Brain Reward Functional Connectivity and Homeostasis Redeeming Joy

Overview
Journal J Behav Addict
Publisher Akademiai Kiado
Date 2015 Jul 2
PMID 26132915
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lucid dreams are frequently pleasant and training techniques have been developed to teach dreamers to induce them. In addition, the induction of lucid dreams has also been used as a way to ameliorate nightmares. On the other hand, lucid dreams may be associated with psychiatric conditions, including Post-Traumatic Stress Disorder (PTSD) and Reward Deficiency Syndrome-associated diagnoses. In the latter conditions, lucid dreams can assume an unpleasant and frequently terrifying character.

Case Presentations: We present two cases of dramatic alleviation of terrifying lucid dreams in patients with PTSD. In the first case study, a 51-year-old, obese woman, diagnosed with PTSD and depression, had attempted suicide and experienced terrifying lucid nightmares linked to sexual/physical abuse from early childhood by family members including her alcoholic father. Her vivid "bad dreams" remained refractory in spite of 6 months of treatment with Dialectical Behavioral Therapy (DBT) and standard pharmaceutical agents which included prazosin, clonidie and Adderall. The second 39-year-old PTSD woman patient had also suffered from lucid nightmares.

Results: The medication visit notes reveal changes in the frequency, intensity and nature of these dreams after the complex putative dopamine agonist KB220Z was added to the first patient's regimen. The patient reported her first experience of an extended period of happy dreams. The second PTSD patient, who had suffered from lucid nightmares, was administered KB220Z to attenuate methadone withdrawal symptoms and incidentally reported dreams full of happiness and laughter.

Conclusions: These cases are discussed with reference to the known effects of KB220Z including enhanced dopamine homeostasis and functional connectivity of brain reward circuitry in rodents and humans. Their understanding awaits intensive investigation involving large-population, double-blinded studies.

Citing Articles

Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.

Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, Norling B J Addict Psychiatry. 2024; 8(1):50-95.

PMID: 39635461 PMC: 11615735.


Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 Analogs.

Modestino E, Bowirrat A, Baron D, Thanos P, Hanna C, Bagchi D J Addict Psychiatry. 2024; 8(1):34-49.

PMID: 39618491 PMC: 11606528.


Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography.

Blum K, Baron D, Mclaughlin T, Thanos P, Dennen C, Ceccanti M J Addict Psychiatry. 2024; 8(1):1-33.

PMID: 38765881 PMC: 11100022.


Molecular pathways underlying sympathetic autonomic overshooting leading to fear and traumatic memories: looking for alternative therapeutic options for post-traumatic stress disorder.

Azevedo M, Martinho R, Oliveira A, Correia-de-Sa P, Moreira-Rodrigues M Front Mol Neurosci. 2024; 16:1332348.

PMID: 38260808 PMC: 10800988. DOI: 10.3389/fnmol.2023.1332348.


Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis.

Blum K, Gold M, Cadet J, Gondre-Lewis M, Mclaughlin T, Braverman E Med Res Arch. 2023; 11(8).

PMID: 37885438 PMC: 10601302. DOI: 10.18103/mra.v11i8.4211.


References
1.
Kovachy B, OHara R, Hawkins N, Gershon A, Primeau M, Madej J . Sleep disturbance in pediatric PTSD: current findings and future directions. J Clin Sleep Med. 2013; 9(5):501-10. PMC: 3629326. DOI: 10.5664/jcsm.2678. View

2.
Schredl M, Bohusch C, Kahl J, Mader A, Somesan A . The use of dreams in psychotherapy: a survey of psychotherapists in private practice. J Psychother Pract Res. 2000; 9(2):81-7. PMC: 3330585. View

3.
Rosen J, Reynolds 3rd C, Yeager A, Houck P, Hurwitz L . Sleep disturbances in survivors of the Nazi Holocaust. Am J Psychiatry. 1991; 148(1):62-6. DOI: 10.1176/ajp.148.1.62. View

4.
Thompson D, Pierce D . Drug-induced nightmares. Ann Pharmacother. 1999; 33(1):93-8. DOI: 10.1345/aph.18150. View

5.
Spoormaker V, Schredl M, van den Bout J . Nightmares: from anxiety symptom to sleep disorder. Sleep Med Rev. 2005; 10(1):19-31. DOI: 10.1016/j.smrv.2005.06.001. View